-
Taxonomy & unit
-
us-gaap: CAD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Evome Medical Technologies Inc. quarterly/annual Revenues history and growth rate from Q2 2020 to Q4 2023.
- Evome Medical Technologies Inc. Revenues for the quarter ending December 31, 2023 was -CA$37.6M, a 456% decline year-over-year.
- Evome Medical Technologies Inc. Revenues for the twelve months ending December 31, 2023 was CA$62.6M, a 56.6% increase year-over-year.
- Evome Medical Technologies Inc. annual Revenues for 2023 was CA$62.6M.
- Evome Medical Technologies Inc. annual Revenues for 2021 was CA$18.3M.
Revenues, Trailing 12 Months (CAD)
Revenues, Quarterly (CAD)
Revenues, YoY Quarterly Growth (%)